INTERMACS Profiles and Outcomes Among Non–Inotrope-Dependent Outpatients With Heart Failure and Reduced Ejection Fraction
Lifestyle Modifications for Preventing and Treating Heart Failure
Economic and Quality-of-Life Outcomes of Natriuretic Peptide–Guided Therapy for Heart Failure
Association of Reduced Apical Untwisting With Incident HF in Asymptomatic Patients With HF Risk Factors
The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5)
Dapagliflozin for treating chronic heart failure with reduced ejection fraction
The conductive function of biopolymer corrects myocardial scar conduction blockage and resynchronizes contraction to prevent heart failure
The Future of Biomarker-Guided Therapy for Heart Failure After the Guiding Evidence-Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) Study